Sofinnova Venture Partners IX, L.P. → NextCure, Inc. NXTC

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

1 13D/G filings on this issuer

0 other filings besides this one

Filer Track Record

8 filings by this filer

7 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 1.63

55,520 shares short · -1.6% vs prior

Other Filings by Sofinnova Venture Partners IX, L.P.

Filed	Form	Issuer	Stake	Shares
2021-03-04	SC	Entasis Therapeutics Holdings Inc.	—	—	view →
2020-06-05	SC	Iterum Therapeutics plc ITRMF	—	—	view →
2020-04-27	SC	Merus N.V.	—	—	view →
2020-01-27	SC	Iterum Therapeutics plc ITRMF	—	—	view →
2019-02-12	SC	aTYR PHARMA INC ATYR	—	—	view →
2019-02-12	SC	Ascendis Pharma A/S ASND	—	—	view →
2019-01-11	SC	Ascendis Pharma A/S ASND	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →